Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders

References

• Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111:52–13. doi:10.1093/bja/aet127. PMID: 23794645.
   PubMed Web of Science ®Google Scholar
• Navratilova E, Fillingim RB, Porreca F. Sexual dimorphism in functional pain syndromes. Sci Transl Med. 2021;13:eabj7180. doi:10.1126/scitranslmed.abj7180. PMID: 34757805.
   PubMed Web of Science ®Google Scholar
• Hoffmann RG, Kotchen JM, Kotchen TA, Cowley T, Dasgupta M, Cowley AW Jr. Temporomandibular disorders and associated clinical comorbidities. Clin J Pain. 2011;27(3):268–74. doi:10.1097/AJP.0b013e31820215f5. PMID: 21178593.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache. 2001;41(7):646–57. doi:10.1046/j.1526-4610.2001.041007646.x. PMID: 11554952.
   PubMed Web of Science ®Google Scholar
• Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990;99(2):409–15. doi:10.1016/0016-5085(90)91023-y. PMID: 2365191.
   PubMed Web of Science ®Google Scholar
• Yunus MB. The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep. 2001;3(2):128–34. PMID: 11286669. doi:10.1007/s11926-001-0008-3.
   PubMedGoogle Scholar
• Bornstein J, Preti M, Simon JA, As-Sanie S, Stockdale CK, Stein A, Parish SJ, Radici G, Vieira-Baptista P, Pukall C, et al. Descriptors of Vulvodynia: A multisocietal definition consensus (International Society for the study of Vulvovaginal disease, the International Society for the study of women sexual health, and the International Pelvic pain Society). J Low Genit Tract Dis. 2019;23(2):161–63. doi:10.1097/LGT.0000000000000461. PMID: 30768446.
   PubMed Web of Science ®Google Scholar
• Fuldeore MJ, Soliman AM. Prevalence and symptomatic burden of diagnosed endometriosis in the United States: National estimates from a cross-sectional survey of 59,411 women. Gynecol Obstet Invest. 2017;82(5):453–61. PMID: 27820938. doi:10.1159/000452660.
   PubMed Web of Science ®Google Scholar
• Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics. 1981;68(5):661–64. doi:10.1542/peds.68.5.661. PMID: 7312467.
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine and the menopause. J Br Menopause Soc. 2006;12:104–08. doi:10.1258/136218006778234048. PMID: 16953983.
   PubMedGoogle Scholar
• Vetvik KG, Macgregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia. 2014;34(4):280–88. doi:10.1177/0333102413507637. PMID: 24101732.
   PubMed Web of Science ®Google Scholar
• Slatculescu AM, Chen Y. Synergism between female gender and high levels of daily stress associated with migraine Headaches in Ontario, Canada. Neuroepidemiology. 2018;51(3–4):183–89. doi:10.1159/000492503. PMID: 30153678.
   PubMed Web of Science ®Google Scholar
• Takeda T, Tadakawa M, Koga S, Nagase S, Yaegashi N. Relationship between dysmenorrhea and posttraumatic stress disorder in Japanese high school students 9 months after the Great East Japan Earthquake. J Pediatr Adolesc Gynecol. 2013;26:355–57. doi:10.1016/j.jpag.2013.06.020. PMID: 24075088.
   PubMed Web of Science ®Google Scholar
• Brasil DL, Montagna E, Trevisan CM, La Rosa VL, Lagana AS, Barbosa CP, Bianco B, Zaia V. Psychological stress levels in women with endometriosis: systematic review and meta-analysis of observational studies. Minerva Med. 2020;111(1):90–102. doi:10.23736/S0026-4806.19.06350-X. PMID: 31755674.
   PubMed Web of Science ®Google Scholar
• Chen Y, Moutal A, Navratilova E, Kopruszinski C, Yue X, Ikegami M, Chow M, Kanazawa I, Bellampalli SS, Xie J, et al. The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females. Sci Transl Med. 2020;12(529):12. doi:10.1126/scitranslmed.aay7550. PMID: 32024801.
   Web of Science ®Google Scholar
• Chen Y, Navratilova E, Dodick DW, Porreca F. An emerging role for prolactin in female-selective pain. Trends Neurosci. 2020;43(8):635–48. doi:10.1016/j.tins.2020.06.003. PMID: 32620290.
   PubMed Web of Science ®Google Scholar
• Belugin S, Diogenes AR, Patil MJ, Ginsburg E, Henry MA, Akopian AN. Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons. J Biol Chem. 2013;288:34943–55. doi:10.1074/jbc.M113.486571. PMID: 24142695.
   PubMed Web of Science ®Google Scholar
• Diogenes A, Patwardhan AM, Jeske NA, Ruparel NB, Goffin V, Akopian AN, Hargreaves KM. Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J Neurosci. 2006;26(31):8126–36. doi:10.1523/JNEUROSCI.0793-06.2006. PMID: 16885226.
   PubMed Web of Science ®Google Scholar
• Patil M, Hovhannisyan AH, Wangzhou A, Mecklenburg J, Koek W, Goffin V, Grattan D, Boehm U, Dussor G, Price TJ, et al. Prolactin receptor expression in mouse dorsal root ganglia neuronal subtypes is sex-dependent. J Neuroendocrinol. 2019;31(8):e12759. doi:10.1111/jne.12759. PMID: 31231869.
   PubMed Web of Science ®Google Scholar
• Patil M, Belugin S, Mecklenburg J, Wangzhou A, Paige C, Barba-Escobedo PA, Boyd JT, Goffin V, Grattan D, Boehm U, et al. Prolactin regulates pain responses via a female-selective nociceptor-specific mechanism. iScience. 2019;20:449–65. doi:10.1016/j.isci.2019.09.039. PMID: 31627131.
   PubMed Web of Science ®Google Scholar
• Patil MJ, Green DP, Henry MA, Akopian AN. Sex-dependent roles of prolactin and prolactin receptor in postoperative pain and hyperalgesia in mice. Neuroscience. 2013;253:132–41. doi:10.1016/j.neuroscience.2013.08.035. PMID: 23994182.
   PubMed Web of Science ®Google Scholar
• Patil MJ, Ruparel SB, Henry MA, Akopian AN. Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: Contribution of prolactin receptor to inflammatory pain. Am J Physiol Endocrinol Metab. 2013;305(9):E1154–E64. doi:10.1152/ajpendo.00187.2013. PMID: 24022869.
   PubMed Web of Science ®Google Scholar
• Scotland PE, Patil M, Belugin S, Henry MA, Goffin V, Hargreaves KM, Akopian AN. Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia. Eur J Neurosci. 2011;34:745–54. doi:10.1111/j.1460-9568.2011.07788.x. PMID: 21777304.
   PubMed Web of Science ®Google Scholar
• Al-Karagholi MA, Kalatharan V, Ghanizada H, Dussor G, Ashina M. Prolactin in headache and migraine: A systematic review of preclinical studies. Headache. 2023;63(5):577–84. doi:10.1111/head.14412. PMID: 36752584.
   PubMed Web of Science ®Google Scholar
• Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002;64(1):47–67. doi:10.1146/annurev.physiol.64.081501.131049. PMID: 11826263.
   PubMedGoogle Scholar
• Bernard V, Young J, Binart N. Prolactin — a pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019;15(6):356–65. doi:10.1038/s41574-019-0194-6. PMID: 30899100.
   PubMed Web of Science ®Google Scholar
• Marano RJ, Ben-Jonathan N. Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions. Molecular Endocrinology. 2014;28(5):622–33. doi:10.1210/me.2013-1349. PMID: 24694306.
   PubMedGoogle Scholar
• Lennartsson AK, Jonsdottir IH. Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology. 2011;36(10):1530–39. doi:10.1016/j.psyneuen.2011.04.007. PMID: 21621331.
   PubMed Web of Science ®Google Scholar
• Tanner MJ, Hadlow NC, Wardrop R. Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust N Z J Obstet Gynaecol. 2011;51:321–24. doi:10.1111/j.1479-828X.2011.01321.x. PMID: 21806583.
   PubMed Web of Science ®Google Scholar
• Bernichtein S, Touraine P, Goffin V. New concepts in prolactin biology. J Endocrinol. 2010;206:1–11. doi:10.1677/JOE-10-0069. PMID: 20371569.
   PubMed Web of Science ®Google Scholar
• Al-Karagholi MA, Kalatharan V, Ghanizada H, Gram C, Dussor G, Ashina M. Prolactin in headache and migraine: A systematic review of clinical studies. Cephalalgia. 2023;43(2):3331024221136286. doi:10.1177/03331024221136286. PMID: 36718026.
   Web of Science ®Google Scholar
• Auriemma RS, Del Vecchio G, Scairati R, Pirchio R, Liccardi A, Verde N, de Angelis C, Menafra D, Pivonello C, Conforti A, et al. The Interplay between prolactin and reproductive System: Focus on Uterine pathophysiology. Front Endocrinol (Lausanne). 2020;11:594370. doi:10.3389/fendo.2020.594370. PMID: 33162942.
   PubMed Web of Science ®Google Scholar
• Bussone G, Usai S, Moschiano F. How to investigate and treat: headache and hyperprolactinemia. Curr Pain Headache Rep. 2012;16(4):365–70. doi:10.1007/s11916-012-0267-x. PMID: 22639180.
   PubMed Web of Science ®Google Scholar
• Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V, Kuttenn F, Kelly PA, Touraine P. Benign breast diseases. J Mammary Gland Biol Neoplasia. 2005;10(4):325–35. doi:10.1007/s10911-006-9006-4. PMID: 16900392.
   PubMed Web of Science ®Google Scholar
• De Hert M, Detraux J, Stubbs B. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review. Expert Opin Drug Saf. 2016;15:809–23. doi:10.1517/14740338.2016.1167873. PMID: 26986209.
   PubMed Web of Science ®Google Scholar
• Hirschowitz JS, Soler NG, Wortsman J. The galactorrhoea-endometriosis syndrome. Lancet. 1978;311(8070):896–98. doi:10.1016/s0140-6736(78)90679-7. PMID: 76843.
   Google Scholar
• Rastrelli G, Corona G, Maggi M. The role of prolactin in andrology: what is new? Rev Endocr Metab Disord. 2015;16(3):233–48. doi:10.1007/s11154-015-9322-3. PMID: 26542707.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Kopruszinski CM, Moutal A, Ikegami D, Khanna R, Chen Y, Ross S, Mackenzie K, Stratton J, Dodick DW, et al. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. Brain. 2022;145(8):2894–909. doi:10.1093/brain/awac104. PMID: 35325034.
   PubMed Web of Science ®Google Scholar
• Avona A, Mason BN, Burgos-Vega C, Hovhannisyan AH, Belugin SN, Mecklenburg J, Goffin V, Wajahat N, Price TJ, Akopian AN, et al. Meningeal CGRP-Prolactin interaction evokes female-specific migraine behavior. Ann Neurol. 2021;89(6):1129–44. doi:10.1002/ana.26070. PMID: 33749851.
   PubMed Web of Science ®Google Scholar
• Kallestrup MM, Kasch H, Osterby T, Nielsen E, Jensen TS, Jorgensen JO. Prolactinoma-associated headache and dopamine agonist treatment. Cephalalgia. 2014;34(7):493–502. doi:10.1177/0333102413515343. PMID: 24351278.
   PubMed Web of Science ®Google Scholar
• Noori-Zadeh A, Karamkhani M, Seidkhani-Nahal A, Khosravi A, Darabi S. Evidence for hyperprolactinemia in migraineurs: a systematic review and meta-analysis. Neurol Sci. 2020;41(1):91–99. doi:10.1007/s10072-019-04035-7. PMID: 31444732.
   PubMed Web of Science ®Google Scholar
• Oliveira MDC, Barea LM, Horn APK, Ongaratti BR, Soares JOD, Araujo B, Santos TMD, Rech CL, Pereira-Lima JFS. Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients. Arq Neuropsiquiatr. 2020;78(1):28–33. doi:10.1590/0004-282X20190143. PMID: 32074187.
   PubMed Web of Science ®Google Scholar
• Gerlo S, Davis JR, Mager DL, Kooijman R. Prolactin in man: a tale of two promoters. Bioessays. 2006;28(10):1051–55.doi:10.1002/bies.20468. PMID: 16998840.
   PubMed Web of Science ®Google Scholar
• Goffin V, Touraine P, Culler MD, Kelly PA. Drug insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? Nat Clin Pract Endocrinol Metab. 2006;2(10):571–81. doi:10.1038/ncpendmet0270. PMID: 17024156.
   PubMedGoogle Scholar
• Liu T, Joo SH, Voorhees JL, Brooks CL, Pei D. Synthesis and screening of a cyclic peptide library: discovery of small-molecule ligands against human prolactin receptor. Bioorg Med Chem. 2009;17(3):1026–33. doi:10.1016/j.bmc.2008.01.015. PMID: 18234500.
   PubMed Web of Science ®Google Scholar
• Otto C, Sarnefalt A, Ljungars A, Wolf S, Rohde-Schulz B, Fuchs I, Schkoldow J, Mattsson M, Vonk R, Harrenga A, et al. A neutralizing prolactin receptor antibody Whose in vivo application Mimics the phenotype of female prolactin receptor-deficient mice. Endocrinology. 2015;156(11):4365–73. doi:10.1210/en.2015-1277. PMID: 26284426.
   PubMed Web of Science ®Google Scholar
• Damiano JS, Rendahl KG, Karim C, Embry MG, Ghoddusi M, Holash J, Fanidi A, Abrams TJ, Abraham JA. Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer. Mol Cancer Ther. 2013;12(3):295–305. doi:10.1158/1535-7163.MCT-12-0886. PMID: 23270929.
   PubMed Web of Science ®Google Scholar
• Goffin V, Bernichtein S, Kayser C, Kelly PA. Development of new prolactin analogs acting as pure prolactin receptor antagonists. Pituitary. 2003;6(2):89–95. doi:10.1023/b:pitu.0000004799.41035.9f. PMID: 14703018.
   PubMedGoogle Scholar
• Chen WY, Ramamoorthy P, Chen N, Sticca R, Wagner TE. A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin Cancer Res. 1999;5:3583–93. https://www.ncbi.nlm.nih.gov/pubmed/10589775.
   PubMed Web of Science ®Google Scholar
• Yu S, Alkharusi A, Norstedt G, Graslund T, Henry KA. An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation. PLoS One. 2019;14(5):e0215831. doi:10.1371/journal.pone.0215831. PMID: 31063493.
   PubMed Web of Science ®Google Scholar
• Goffin V, Shiverick KT, Kelly PA, Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev. 1996;17(4):385–410. doi:10.1210/edrv-17-4-385. PMID: 8854051.
   PubMed Web of Science ®Google Scholar
• Padros J, Chatel G, Caron M. Time-resolved Förster Resonance energy transfer assays for measurement of endogenous Phosphorylated STAT proteins in human cells. JoVe (J Visualized Exp). 2021;175. doi:10.3791/62915-v. PMID: 34570089.
   PubMed Web of Science ®Google Scholar
• Silva JP, Vetterlein O, Jose J, Peters S, Kirby H. The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation. J Biol Chem. 2015;290(9):5462–69. doi:10.1074/jbc.M114.600973. PMID: 25568323.
   PubMed Web of Science ®Google Scholar
• Yu J, Song Y, Tian W. How to select IgG subclasses in developing anti-tumor therapeutic antibodies. J Hematol Oncol. 2020;13(1):45. doi:10.1186/s13045-020-00876-4. PMID: 32370812.
   PubMed Web of Science ®Google Scholar
• Chenoweth AM, Wines BD, Anania JC, Mark Hogarth P. Harnessing the immune system via FcγR function in immune therapy: a pathway to next-gen mAbs. Immunol Cell Biol. 2020;98(4):287–304. doi:10.1111/imcb.12326. PMID: 32157732.
   PubMed Web of Science ®Google Scholar
• Avery LB, Wang M, Kavosi MS, Joyce A, Kurz JC, Fan YY, Dowty ME, Zhang M, Zhang Y, Cheng A, et al. Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. MAbs. 2016;8(6):1064–78. doi:10.1080/19420862.2016.1193660. PMID: 27232760.
   PubMed Web of Science ®Google Scholar
• Mason BN, Kallianpur R, Price TJ, Akopian AN, Dussor GO. Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine. Headache. 2022;62(1):11–25. doi:10.1111/head.14248. PMID: 34967003.
   PubMed Web of Science ®Google Scholar
• Christensen HR, Murawsky MK, Horseman ND, Willson TA, Gregerson KA. Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues. Endocrinology. 2013;154(12):4777–89. doi:10.1210/en.2013-1476. PMID: 24029242.
   PubMed Web of Science ®Google Scholar
• Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, Rui H. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. J Endocrinol. 2006;188(3):589–601. doi:10.1677/joe.1.06560. PMID: 16522738.
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Low BE, Christianson GJ, Proetzel G, Sproule TJ, Wiles MV. Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs. MAbs. 2015;7(2):344–51. doi:10.1080/19420862.2015.1008345. PMID: 25654695.
   PubMed Web of Science ®Google Scholar
• Nakamura G, Ozeki K, Takesue H, Tabo M, Hosoya KI. Prediction of human pharmacokinetics profile of monoclonal antibody using hFcrn transgenic mouse model. Biol Pharm Bull. 2021;44:389–95. doi:10.1248/bpb.b20-00775. PMID: 33642546.
   PubMed Web of Science ®Google Scholar
• Betts A, Keunecke A, van Steeg TJ, van der Graaf PH, Avery LB, Jones H, Berkhout J, van Steeg TJ, van der Graaf PH. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcrn Tg32 transgenic mouse using a population-modeling approach. MAbs. 2018;10(5):751–64. doi:10.1080/19420862.2018.1462429. PMID: 29634430.
   PubMed Web of Science ®Google Scholar
• Bruhns P, Jonsson F. Mouse and human FcR effector functions. Immunol Rev. 2015;268(1):25–51. doi:10.1111/imr.12350. PMID: 26497511.
   PubMed Web of Science ®Google Scholar
• Otto C, Wolf S, Freiberg C, Harrenga A, Greven S, Trautwein M, Bruder S, Eicker A, Wilen A. Neutralizing prolactin receptor antibodies and their therapeutic use. WO 2011/069799 A1. World Intellectual Property Organization; 2011.
   Google Scholar
• Kelly PA, Binart N, Freemark M, Lucas B, Goffin V, Bouchard B. Prolactin receptor signal transduction pathways and actions determined in prolactin receptor knockout mice. Biochem Soc Trans. 2001;29(2):48–52. doi:10.1042/0300-5127:0290048. PMID: 11356125.
   PubMedGoogle Scholar
• LaPensee CR, Horseman ND, Tso P, Brandebourg TD, Hugo ER, Ben-Jonathan N. The prolactin-deficient mouse has an unaltered metabolic phenotype. Endocrinology. 2006;147(10):4638–45. doi:10.1210/en.2006-0487. PMID: 16809445.
   PubMed Web of Science ®Google Scholar
• Lee GJ, Porreca F, Navratilova E. Prolactin and pain of endometriosis. Pharmacology & Therapeutics. 2023;247:108435. doi:10.1016/j.pharmthera.2023.108435. PMID: 37169264.
   PubMed Web of Science ®Google Scholar
• De LD, Becerra A, Lahera M, JI B, Valero VC, Varela C. A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients. J Endocrinol Invest. 2000;23(7):428–34. doi:10.1007/BF03343751. PMID: 11005266.
   PubMed Web of Science ®Google Scholar
• FDA. Labelling-Package insert for New Drug application (NDA): 020664. Updated 12/13/2019, FDA, drugs@FDA; 1996.
   Google Scholar
• Leanos-Miranda A, Pascoe-Lira D, Chavez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol. 2001;28(7):1546–53. https://www.ncbi.nlm.nih.gov/pubmed/11469460. PMID: 11469460.
   PubMed Web of Science ®Google Scholar
• Blanco-Favela F, Quintal Ma G, Chavez-Rueda AK, Leanos-Miranda A, Berron-Peres R, Baca-Ruiz V, Lavalle-Montalvo C. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients. Lupus. 2001;10(11):803–08. doi:10.1177/096120330101001107. PMID: 11789490.
   PubMed Web of Science ®Google Scholar
• Leanos-Miranda A, Chavez-Rueda KA, Blanco-Favela F. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 2001;44:866–75. doi:10.1002/1529-013120010444:4<866:AID-ANR143>3.0.CO;2-6. PMID: 11315926.
   PubMedGoogle Scholar
• FDA. CDER review for new drug application (NDA): 020664. FDA, Drugs@FDA. 1996.
   Google Scholar
• Stubenrauch K, Wessels U, Regula JT, Kettenberger H, Schleypen J, Kohnert U. Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys. Drug Metab Dispos. 2010;38(1):84–91. doi:10.1124/dmd.109.029751. PMID: 19850673.
   PubMed Web of Science ®Google Scholar
• Lewis KB, Meengs B, Bondensgaard K, Chin L, Hughes SD, Kjaer B, Lund S, Wang L. Comparison of the ability of wild type and stabilized human IgG(4) to undergo Fab arm exchange with endogenous IgG(4)in vitro and in vivo. Mol Immunol. 2009;46(16):3488–94. doi:10.1016/j.molimm.2009.07.009. PMID: 19683345.
   PubMed Web of Science ®Google Scholar
• Wang C, Thudium KB, Han M, Wang XT, Huang H, Feingersh D, Garcia C, Wu Y, Kuhne M, Srinivasan M, et al. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014;2(9):846–56. doi:10.1158/2326-6066.CIR-14-0040. PMID: 24872026.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang F, Zhang Y, Wang L, Antonenko S, Zhang S, Zhang YW, Tabrizifard M, Ermakov G, Wiswell D, et al. Comprehensive analysis of the therapeutic IgG4 antibody pembrolizumab: hinge modification blocks half molecule exchange in vitro and in vivo. J Pharm Sci. 2015;104(12):4002–14. doi:10.1002/jps.24620. PMID: 26308749.
   PubMed Web of Science ®Google Scholar
• Nath N, Godat B, Flemming R, Urh M. A homogeneous bioluminescent immunoassay for parallel characterization of binding between a panel of antibodies and a family of Fcγ receptors. Sci Rep. 2022;12(1):12185. doi:10.1038/s41598-022-15887-z. PMID: 35842448.
   PubMed Web of Science ®Google Scholar
• Chai Q, Shih J, Weldon C, Phan S, Jones BE. Development of a high-throughput solubility screening assay for use in antibody discovery. MAbs. 2019;11(4):747–56. doi:10.1080/19420862.2019.1589851. PMID: 30913963.
   PubMed Web of Science ®Google Scholar
• Abanades B, Wong WK, Boyles F, Georges G, Bujotzek A, CM D. ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins. bioRxiv. 2022;2022 2011.2004.514231. doi:10.1101/2022.11.04.514231.
   Google Scholar
• Raybould MIJ, Marks C, Krawczyk K, Taddese B, Nowak J, Lewis AP, Bujotzek A, Shi J, Deane CM. Five computational developability guidelines for therapeutic antibody profiling. Proc Natl Acad Sci U S A. 2019;116:4025–30. doi:10.1073/pnas.1810576116. PMID: 30765520.
   PubMed Web of Science ®Google Scholar
• Gao SH, Huang K, Tu H, Adler AS. Monoclonal antibody humanness score and its applications. BMC Biotechnol. 2013;13:55. doi:10.1186/1472-6750-13-55. PMID: 23826749.
   PubMed Web of Science ®Google Scholar
• Kozlowski LP. IPC – Isoelectric Point Calculator. Biol Direct. 2016;11(1):55. doi:10.1186/s13062-016-0159-9.
   PubMed Web of Science ®Google Scholar
• Grimsley GR, Scholtz JM, Pace CN. A summary of the measured pK values of the ionizable groups in folded proteins. Protein Sci. 2009;18:247–51. doi:10.1002/pro.19. PMID: 19177368.
   PubMed Web of Science ®Google Scholar
• Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53(1):55–63. doi:10.1016/0165-0270(94)90144-9. PMID: 7990513.
   PubMed Web of Science ®Google Scholar